Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ArriVent BioPharma, Inc. | 1,291,442 | reported | 30 Jan 2024 | tx 10+3,027,328−2,582,884 |
| Kinnate Biopharma Inc. | 0 | reported | 03 Apr 2024 | tx 5−8,009,729 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 03 Apr 2024 | OTHER | Kinnate Biopharma Inc. | 4,738,453 | — | |
| 03 Apr 2024 | OTHER | Kinnate Biopharma Inc. | 1,368,339 | — | |
| 03 Apr 2024 | OTHER | Kinnate Biopharma Inc. | 1,368,338 | — | |
| 03 Apr 2024 | OTHER | Kinnate Biopharma Inc. | 450,000 | — | |
| 03 Apr 2024 | OTHER | Kinnate Biopharma Inc. | 84,599 | — | |
| 30 Jan 2024 | PURCHASE | ArriVent BioPharma, Inc. | 222,222 | 18.00 USD | |
| 30 Jan 2024 | PURCHASE | ArriVent BioPharma, Inc. | 222,222 | 18.00 USD | |
| 30 Jan 2024 | CONVERSION | ArriVent BioPharma, Inc. | 469,615 | — | |
| 30 Jan 2024 | CONVERSION | ArriVent BioPharma, Inc. | 469,615 | — | |
| 30 Jan 2024 | CONVERSION | ArriVent BioPharma, Inc. | 821,827 | — | |
| 30 Jan 2024 | CONVERSION | ArriVent BioPharma, Inc. | 821,827 | — | |
| 30 Jan 2024 | CONVERSION | ArriVent BioPharma, Inc. | 821,827 | — | deriv |
| 30 Jan 2024 | CONVERSION | ArriVent BioPharma, Inc. | 821,827 | — | deriv |
| 30 Jan 2024 | CONVERSION | ArriVent BioPharma, Inc. | 469,615 | — | deriv |
| 30 Jan 2024 | CONVERSION | ArriVent BioPharma, Inc. | 469,615 | — | deriv |